ChAc is a loss‐of‐function disorder, and the VPS13A pathogenic mutations usually lead to highly reduced levels or absence of VPS13A protein (chorein) (Dobson‐Stone et al., 2004). Here, VPS13A is linked to Choreoacanthocytosis.